INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,217,000 | -11.0% | 43,183 | -9.2% | 0.00% | +33.3% |
| Q3 2018 | $1,367,000 | -25.6% | 47,562 | -3.1% | 0.00% | -40.0% |
| Q2 2018 | $1,838,000 | -5.3% | 49,078 | -0.6% | 0.01% | 0.0% |
| Q1 2018 | $1,940,000 | +31.3% | 49,376 | +8.3% | 0.01% | +25.0% |
| Q4 2017 | $1,477,000 | +11.4% | 45,586 | +7.1% | 0.00% | 0.0% |
| Q3 2017 | $1,326,000 | +14.3% | 42,565 | +2.5% | 0.00% | 0.0% |
| Q2 2017 | $1,160,000 | +70.3% | 41,515 | +4.6% | 0.00% | +100.0% |
| Q1 2017 | $681,000 | +36.5% | 39,680 | -3.8% | 0.00% | 0.0% |
| Q4 2016 | $499,000 | -69.7% | 41,260 | -60.3% | 0.00% | -66.7% |
| Q3 2016 | $1,645,000 | -22.4% | 103,841 | -36.7% | 0.01% | -25.0% |
| Q2 2016 | $2,121,000 | -9.0% | 164,031 | +33.7% | 0.01% | 0.0% |
| Q1 2016 | $2,331,000 | +23.5% | 122,671 | +46.2% | 0.01% | +14.3% |
| Q4 2015 | $1,887,000 | +132.1% | 83,885 | +141.6% | 0.01% | +133.3% |
| Q3 2015 | $813,000 | – | 34,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |